
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16413262
[patent_doc_number] => 10821123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Use of ribose for treatment of subjects having congestive heart failure
[patent_app_type] => utility
[patent_app_number] => 15/409735
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3591
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409735
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/409735 | Use of ribose for treatment of subjects having congestive heart failure | Jan 18, 2017 | Issued |
Array
(
[id] => 13837273
[patent_doc_number] => 20190022121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => MODULATORS OF ZINC ACTIVATED CATION CHANNEL
[patent_app_type] => utility
[patent_app_number] => 16/068814
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068814 | Modulators of zinc activated cation channel | Jan 10, 2017 | Issued |
Array
(
[id] => 13714081
[patent_doc_number] => 20170367995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => TREATMENT OF EARLY STAGE PARKINSON'S DISEASE WITH A HYDROXYTYROSOL-CONTAINING POLYPHENOL FORMULATION
[patent_app_type] => utility
[patent_app_number] => 15/394784
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15394784
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/394784 | TREATMENT OF EARLY STAGE PARKINSON'S DISEASE WITH A HYDROXYTYROSOL-CONTAINING POLYPHENOL FORMULATION | Dec 28, 2016 | Abandoned |
Array
(
[id] => 16229381
[patent_doc_number] => 10736911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Use of a DHODH inhibitor in combination with an inhibitor of pyrimidine salvage
[patent_app_type] => utility
[patent_app_number] => 16/063113
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 62
[patent_no_of_words] => 27235
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063113
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063113 | Use of a DHODH inhibitor in combination with an inhibitor of pyrimidine salvage | Dec 21, 2016 | Issued |
Array
(
[id] => 13760975
[patent_doc_number] => 10172816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Method of treating chronic obstructive pulmonary disease (CPD) with verproside
[patent_app_type] => utility
[patent_app_number] => 15/384302
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 19251
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15384302
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/384302 | Method of treating chronic obstructive pulmonary disease (CPD) with verproside | Dec 18, 2016 | Issued |
Array
(
[id] => 13618935
[patent_doc_number] => 20180361019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => HYALURONIC ACID COMPOSITION FOR PENILE INJECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/063360
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063360 | HYALURONIC ACID COMPOSITION FOR PENILE INJECTIONS | Dec 15, 2016 | Abandoned |
Array
(
[id] => 16413265
[patent_doc_number] => 10821126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Agent for treating retinopathy
[patent_app_type] => utility
[patent_app_number] => 16/327649
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 3680
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327649
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327649 | Agent for treating retinopathy | Dec 8, 2016 | Issued |
Array
(
[id] => 11512940
[patent_doc_number] => 20170080013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'METHODS AND COMPOSITIONS FOR DERMATOLOGICAL USE COMPRSING HYDROCORTISONE ACETATE AND BIOPOLYMERS'
[patent_app_type] => utility
[patent_app_number] => 15/368552
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12492
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15368552
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/368552 | METHODS AND COMPOSITIONS FOR DERMATOLOGICAL USE COMPRSING HYDROCORTISONE ACETATE AND BIOPOLYMERS | Dec 1, 2016 | Abandoned |
Array
(
[id] => 14685129
[patent_doc_number] => 20190241679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => Process for the Extraction of Metal Pollutants from Treated Cellulosic Biomass
[patent_app_type] => utility
[patent_app_number] => 15/777360
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777360
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777360 | Process for the extraction of metal pollutants from treated cellulosic biomass | Nov 20, 2016 | Issued |
Array
(
[id] => 15225029
[patent_doc_number] => 10500218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Uptake of pharmaceuticals within cyclodextrin-based porous materials
[patent_app_type] => utility
[patent_app_number] => 15/350975
[patent_app_country] => US
[patent_app_date] => 2016-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 6959
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15350975
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/350975 | Uptake of pharmaceuticals within cyclodextrin-based porous materials | Nov 13, 2016 | Issued |
Array
(
[id] => 14403871
[patent_doc_number] => 20190167779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Synthetic Antigen Constructs Against Campylobacter Jejuni
[patent_app_type] => utility
[patent_app_number] => 15/342813
[patent_app_country] => US
[patent_app_date] => 2016-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15342813
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/342813 | Synthetic antigen constructs against campylobacter jejuni | Nov 2, 2016 | Issued |
Array
(
[id] => 15524961
[patent_doc_number] => 20200054786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => COACERVATE HYALURONAN HYDROGELS FOR DERMAL FILLER APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/341382
[patent_app_country] => US
[patent_app_date] => 2016-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341382 | COACERVATE HYALURONAN HYDROGELS FOR DERMAL FILLER APPLICATIONS | Oct 12, 2016 | Abandoned |
Array
(
[id] => 13533481
[patent_doc_number] => 20180318283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => PHARMACEUTICAL COMPOSITION, USE OF MEFLOQUINE IN A FIXED DOSE, AND METHOD FOR TREATING TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 15/771941
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/771941 | Pharmaceutical composition, use of mefloquine in fixed dose, and method for treating tuberculosis | Oct 6, 2016 | Issued |
Array
(
[id] => 13440695
[patent_doc_number] => 20180271890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir
[patent_app_type] => utility
[patent_app_number] => 15/763649
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763649
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763649 | Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir | Oct 5, 2016 | Abandoned |
Array
(
[id] => 11589676
[patent_doc_number] => 20170114086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => '2\'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/282492
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18494
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15282492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/282492 | 2'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | Sep 29, 2016 | Abandoned |
Array
(
[id] => 12580752
[patent_doc_number] => 20180085413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => TRITERPENOID OBTAINABLE FROM HEDERA HELIX FOR TREATMENT OF NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/280136
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15280136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/280136 | Triterpenoid obtainable from hedera helix for treatment of neurodegenerative diseases | Sep 28, 2016 | Issued |
Array
(
[id] => 11935209
[patent_doc_number] => 20170239358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'Rapid In-situ Gel Forming Compositions Prepared via Reaction of Vinyl Sulfone Derivatized Hyaluronic Acid with Thiol Derivatized Polyethylene Glycol at Alkaline pH'
[patent_app_type] => utility
[patent_app_number] => 15/277928
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15129
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15277928
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/277928 | Rapid In-situ Gel Forming Compositions Prepared via Reaction of Vinyl Sulfone Derivatized Hyaluronic Acid with Thiol Derivatized Polyethylene Glycol at Alkaline pH | Sep 26, 2016 | Abandoned |
Array
(
[id] => 11527200
[patent_doc_number] => 20170087177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'HIGH ELASTICITY HYALURONAN COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/271434
[patent_app_country] => US
[patent_app_date] => 2016-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15485
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15271434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/271434 | High elasticity hyaluronan compositions and methods of use thereof | Sep 20, 2016 | Issued |
Array
(
[id] => 13354571
[patent_doc_number] => 20180228825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => SULFOLIPIDS AS NEW GLUTAMINYL CYCLASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/761060
[patent_app_country] => US
[patent_app_date] => 2016-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761060
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/761060 | SULFOLIPIDS AS NEW GLUTAMINYL CYCLASE INHIBITORS | Sep 14, 2016 | Abandoned |
Array
(
[id] => 12880663
[patent_doc_number] => 20180185396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION
[patent_app_type] => utility
[patent_app_number] => 15/759754
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759754
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/759754 | Synthetic composition for microbiota modulation | Sep 13, 2016 | Issued |